Back to Atlas
APotentially durableStandard research/education caution
CMP-0133
Approved
Testosterone undecanoate / Andriol
Ergogenic / AAS
Systemic androgen replacement/anabolic effect
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Esterified testosterone
- Primary mechanism
- Testosterone prodrug; AR agonist; A:A ratio 1:1 baseline
- Primary market use
- Hypogonadism / androgen replacement
Pharmacology
- Molecular weight (Da)
- 456.71
- Oral bioavailability
- Oral lymphatic absorption; low/variable and food-dependent
- Half-life
- Oral ~3-8 h apparent; IM undecanoate ~20-34 d
- Route tags
- Oral
- Evidence level
- Approved
- Clinical status
- Approved
- Value-for-money score
- 7 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Route matters: oral undecanoate has variable lymphatic absorption, while IM undecanoate has long depot kinetics.